Understanding EU Clinical Trial Regulation Course: EU Filings & Registrations for Drugs & Biologics (ON-DEMAND)
October 08, 2024 12:09 ET
|
Research and Markets
Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "Understanding EU Clinical Trial Regulation - EU Filings & Registrations" report has been added to ResearchAndMarkets.com's offering.The European...
PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA
October 08, 2024 08:55 ET
|
PharmAla Biotech
PharmAla signs contract to develop novel dosage form of LaNeo MDMA, to be used in clinical trial at University of Texas San Antonio
Muscle Invasive Bladder Cancer (MIBC): Key Clinical Trials, Top Countries, Sponsors, and Emerging Trends in 2024
October 02, 2024 09:43 ET
|
Research and Markets
Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...
Adoptive Cell Therapy Clinical Trials Report, 2024: Trends, Key Segments, Top Sponsors, and Virtual Components
October 02, 2024 09:29 ET
|
Research and Markets
Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trials: Adoptive Cell Therapy" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of Adoptive...
PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMA
October 02, 2024 09:20 ET
|
PharmAla Biotech
PharmAla Biotech signs contract to supply Harvard neuropsychiatry hospital with MDMA; Appears at CPHI Conference in Milan
G7 & E7 Sicca Syndrome (Sjogren) Clinical Trials Review 2024: Competitive Landscape, Trial Status, Trial Phase, Sponsor Type and End Point Status
September 30, 2024 10:39 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Sicca Syndrome (Sjogren) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical...
Adaptive Research Announces it has Begun Enrolling Patients in AriBio’s Phase 3 POLARIS-AD Clinical Trial
September 30, 2024 08:00 ET
|
Adaptive Research Inc
Adaptive Research announced it has begun enrolling patients in
AriBio’s Phase 3 POLARIS-AD Clinical Trial.
Generalized Pustular Psoriasis (GPP) Clinical Trials Review, 2024: Uncover Key Investment Strategies with Country-Specific Data by Phase, Trial Status, End Points Status and Sponsor Type
September 30, 2024 06:51 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...
Delirium Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
September 27, 2024 06:57 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Delirium - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering."Delirium - Global Clinical...
Cystic Fibrosis Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
September 27, 2024 06:55 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...